Vir Biotechnology, Inc. Form 4 (Dec. 20, 2021) — SVF Endurance

Summary

SVF Endurance (Cayman) Limited, SoftBank Vision Fund (AIV M1) L.P. and SB Investment Advisers (UK) Limited file this joint Form 4 as 10% owners of Vir Biotechnology, Inc. [VIR]. Table I reports a sale of 400,022 shares of common stock on 12/20/2021 at a weighted average price of $52.73, from transactions priced from $50.90 to $57.82, leaving 22,216,644 shares owned indirectly. A footnote states that SVF Endurance (Cayman) Limited is the record holder and a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P., and that SB Investment Advisers (UK) Limited, as alternative investment fund manager, is exclusively responsible for decisions on the fund's investments. The form is signed /s/ Karen Ellerbe, Director, and /s/ Spencer Collins, General Counsel, on 12/22/2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Vir Biotechnology, Inc. Form 4 (Dec. 20, 2021) — SVF Endurance.” Original at www.sec.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/sec-vir-4-filed2021-12-22-0000899243-21-049394-32200125cc/, SHA-256 b9870ab5f159fad477a1be1192ff27869e7c260625476bb3c3a39547394e420a.

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * SVF Endurance (Cayman) Ltd (Last) (First) (Middle) C/O WALKERS CORP LTD, 190 ELGIN AVENUE (Street) GEORGE TOWN, GRAND CAYMAN E9 KY1-9008 (City) (State) (Zip) | SVF Endurance (Cayman) Ltd | (Last) | (First) | (Middle) | C/O WALKERS CORP LTD, 190 ELGIN AVENUE | GEORGE TOWN, GRAND CAYMAN | E9 | KY1-9008 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Vir Biotechnology, Inc. [ VIR ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below) | Director | X | 10% Owner | Officer (give title below) | Other (specify below)
3. Date of Earliest Transaction
 (Month/Day/Year) 12/20/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person | Form filed by One Reporting Person | X | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 12/20/2021 | S | 400,022 | D | $ 52.73 (1) | 22,216,644 | I | See footnote (2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
1. Name and Address of Reporting Person * SVF Endurance (Cayman) Ltd (Last) (First) (Middle) C/O WALKERS CORP LTD, 190 ELGIN AVENUE (Street) GEORGE TOWN, GRAND CAYMAN E9 KY1-9008 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below) | SVF Endurance (Cayman) Ltd | (Last) | (First) | (Middle) | C/O WALKERS CORP LTD, 190 ELGIN AVENUE | GEORGE TOWN, GRAND CAYMAN | E9 | KY1-9008 | (City) | (State) | (Zip) | Director | X | 10% Owner | Officer (give title below) | Other (specify below)
1. Name and Address of Reporting Person * SB INVESTMENT ADVISERS (UK) LTD (Last) (First) (Middle) 69 GROSVENOR STREET (Street) LONDON X0 W1K 3JP (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below) | SB INVESTMENT ADVISERS (UK) LTD | (Last) | (First) | (Middle) | 69 GROSVENOR STREET | LONDON | X0 | W1K 3JP | (City) | (State) | (Zip) | Director | X | 10% Owner | Officer (give title below) | Other (specify below)
1. Name and Address of Reporting Person * SOFTBANK VISION FUND (AIV M1) L.P. (Last) (First) (Middle) 251 LITTLE FALLS DRIVE (Street) WILMINGTON DE 19808 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below) | SOFTBANK VISION FUND (AIV M1) L.P. | (Last) | (First) | (Middle) | 251 LITTLE FALLS DRIVE | WILMINGTON | DE | 19808 | (City) | (State) | (Zip) | Director | X | 10% Owner | Officer (give title below) | Other (specify below)
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.90 to $57.82. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. SVF Endurance (Cayman) Limited is the record holder of the shares of Common Stock reported herein. SVF Endurance (Cayman) Limited is a wholly owned subsidiary of SoftBank Vision Fund (AIV M1) L.P. ("SVF"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF's investments
Remarks:
SVF Endurance (Cayman) Limited, By: /s/ Karen Ellerbe, Director | 12/22/2021
SoftBank Vision Fund (AIV M1) L.P., By: SB Investment Advisers (UK) Limited, its manager, By: /s/ Spencer Collins, General Counsel | 12/22/2021
SB Investment Advisers (UK) Limited, By: /s/ Spencer Collins, General Counsel | 12/22/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File: SEC_VIR_4_filed2021-12-22_0000899243-21-049394.xml
Size: 22,741 bytes
SHA-256: b9870ab5f159fad477a1be1192ff27869e7c260625476bb3c3a39547394e420a
Our copy: SEC_VIR_4_filed2021-12-22_0000899243-21-049394.xml
Original: www.sec.gov